Top Markets
#1 OpenVPP OpenVPP +13,448.23%
#2 BugsCoin BugsCoin +49.61%
#3 GENIUS AI GENIUS AI +48.16%
#4 TAC TAC +34.76%
#5 Solidus Ai Tech Solidus Ai Tech +30.89%
#6 Zerebro Zerebro +28.49%
#7 Avici Avici +24.70%
#8 Swarms Swarms +19.08%
#9 Resolv RLP Resolv RLP +17.22%
#10 AI Rig Complex AI Rig Complex +12.79%
Coin of the day
OpenVPP OpenVPP
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Hikal Limited Hikal Limited

Hikal Limited

HIKAL
Kedudukan dalam Saham #10836
Hikal Limited, together with its subsidiaries, manufactures and sells various... Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Harga Saham
$2.09
Modal Pasaran
$257.37M
Perubahan (1 hari)
0.76%
Perubahan (1 tahun)
-55.56%
Negara
IN
Perdagangan Hikal Limited (HIKAL)

Kategori

Healthcare
Nisbah P/E bagi Hikal Limited (HIKAL)
Nisbah P/E pada April 2026 TTM: -177.28
Menurut laporan kewangan dan harga saham terkini Hikal Limited, nisbah P/E semasa (TTM) ialah -177.28. Pada akhir 2024, syarikat mempunyai nisbah P/E sebanyak 48.85.
Sejarah nisbah P/E bagi Hikal Limited dari 2005 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
2026 (TTM) -177.28 -425.22%
2025 54.51 11.60%
2024 48.85 10.25%
2023 44.31 43.36%
2022 30.91 132.48%
2021 13.29 30.71%
2020 10.17 -53.22%
2019 21.74 -0.82%
2018 21.92 -15.52%
2017 25.95 10.83%
2016 23.41 -17.83%
2015 28.49 135.54%
2014 12.10 -54.57%
2013 26.63 174.40%
2012 9.70 -24.11%
2011 12.79 5.56%
2010 12.11 99.32%
2009 6.08 -53.66%
2008 13.12 -54.12%
2007 28.58 5.50%
2006 27.09 71.14%
2005 15.83 0.00%
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPSEY.US
 30.58 -117.25%
FR
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MKGAF.US
 19.43 -110.96%
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
TAK.US
 79.16 -144.65%
JP
Zoetis Inc. Zoetis Inc.
Zoetis Inc.
ZTS.US
 19.85 -111.20%
US
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 36.75 -120.73%
IN
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.